Antibiotic resistance is a major public health challenge when it comes to tackling infectious diseases. The Institut Pasteur identified antimicrobial resistance as a priority scientific area in its 2019-2023 Strategic Plan. In a study published recently in the journal mSystems, scientists from the Institut Pasteur analyzed the resistance of Escherichia coli bacteria to carbapenems, a class of antibiotics, depending on their phylogeny and resistance to other antibiotics. This publication was produced in collaboration with the Paris Public Hospital Network (AP-HP) – Bicêtre Hospital, Université Paris-Saclay, CNRS, Inserm and Sorbonne Université.

Find out more